IP Library Granted Patent US 10,744,262
Granted Patent B2
US 10,744,262 · App. 16/183,354 · Granted Aug 18, 2020

System and method for health monitoring by an ear piece

Inventors: Robert Steven Newberry (New Hope, AK); Matthew Rodencal (Huntsville, AL)
Assignee: SANMINA CORPORATION
A61M5/1723A61M5/14248A61M5/3298A61M5/145A61M2205/3306A61M2205/3584A61M2205/502A61M2205/52A61M2205/8206A61M2205/8268A61M2230/06A61M2230/20A61M2230/30A61M2230/42A61M2230/50A61M2230/63
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,744,262
App. No.
16/183,354
Granted
Aug 18, 2020
Kind
B2
Abstract

A biosensor is implemented in an earpiece and includes an activity monitoring circuit that detects an activity level of a user and an optical circuit that detects a plurality of spectral responses at a plurality of wavelengths from light reflected from skin of the user. The biosensor determines a heart rate and an oxygen saturation level using the plurality of spectral responses and determines whether the heart rate or the oxygen saturation level reaches a predetermined threshold for the activity level of the user. The biosensor generates an alert and transmits the alert wirelessly to a remote device.

Claims (77)

1. A biosensor implemented in an ear piece, comprising:

an activity monitoring circuit in the ear piece configured to detect an activity level;

a photoplethysmograpy (PPG) circuit in the ear piece configured to detect a plurality of spectral responses at a plurality of wavelengths from light reflected from skin of a user;

a processing circuit configured to:

determine the activity level indicates a period of sleep;

determine a heart rate and an oxygen saturation level using the plurality of spectral responses;

determine the oxygen saturation level is below a predetermined threshold; and

generate an indication of sleep apnea.

2. The biosensor of claim 1 , further comprising a wireless transceiver configured to communicate over a wireless network; and

wherein the processing circuit is further configured to transmit the indication of sleep apnea over the wireless network to a remote device.

3. The biosensor of claim 1 , wherein the processing circuit is configured to:

determine sodium concentration level in blood flow; and

determine dehydration using the sodium concentration level in blood flow.

4. The biosensor of claim 1 , further comprising a temperature sensor in the ear piece configured to detect a temperature of the user.

5. The biosensor of claim 1 , wherein the processing circuit is configured to:

determine a respiration rate and a blood pressure using the plurality of spectral responses;

determine one or more of: respiration rate, heart rate, or blood pressure has exceeded a predetermined threshold; and

generate an alert for wireless transmission to a remote device.

6. The biosensor of claim 1 , wherein the processing circuit is further configured to:

determine a concentration level of nitric oxide (NO) in blood flow of the user from at least one of the plurality of spectral responses, wherein the at least one of the plurality of spectral responses is obtained at a wavelength with a high absorption coefficient for NO.

7. The biosensor of claim 1 , wherein the processing circuit is further configured to:

determine a concentration level of glucose in blood flow of the user from at least one of the plurality of spectral responses, wherein the at least one of the plurality of spectral responses is obtained at a wavelength with a high absorption coefficient for NO.

8. The biosensor of claim 1 , wherein the processing circuit is further configured to:

determine a concentration level of a medication in blood flow at periodic intervals during the period of sleep using the plurality of spectral responses; and

generate an alert in response to the concentration level of the medication in blood flow reaching a predetermined threshold.

9. A biosensor implemented in an ear piece, comprising:

a photoplethysmograpy (PPG) circuit in the ear piece configured to detect a plurality of spectral responses at a plurality of wavelengths from light reflected from skin of a user;

a processing circuit configured to:

determine a heart rate, an oxygen saturation level and a concentration level of an additional substance in blood flow using the plurality of spectral responses;

determine the heart rate, oxygen saturation level or the concentration level of the additional substance reaches one or more predetermined thresholds; and

generate an alert to the user.

10. The biosensor of claim 9 , further comprising an activity monitoring circuit in the ear piece configured to detect an activity level of the user; and

wherein the processing circuit is configured to determine the heart rate, the oxygen saturation level and the concentration level of an additional substance in blood flow and an associated activity level of the user.

11. The biosensor of claim 9 , wherein the additional substance in blood flow includes: a medication; NO; glucose; a hemoglobin compound; or a protein or other compound associated with cancer, bilirubin amount and potassium.

12. The biosensor of claim 9 , wherein the additional substance in blood flow includes sodium and wherein the processing circuit is configured to determine a dehydration level of the user using the concentration level of sodium in blood flow.

13. The biosensor of claim 9 , wherein the processing circuit is configured to:

determine a respiratory rate or blood pressure using the plurality of spectral responses;

determine at least one of the respiratory rate or the blood pressure has reached a predetermined threshold; and

generate another alert to the user, wherein the another alert is transmitted over a wireless network to a remote device.

14. The biosensor of claim 9 , wherein the processing circuit is further configured to:

determine a concentration level of a medication in blood flow at periodic intervals using the plurality of spectral responses; and

generate an alert in response to the concentration level of the medication reaching a predetermined threshold.

15. The biosensor of claim 9 , wherein the processing circuit is further configured to:

determine a concentration level of nitric oxide (NO) in blood flow of the user from at least one of the plurality of spectral responses, wherein the at least one of the plurality of spectral responses is obtained at a wavelength with a high absorption coefficient for NO; and

generate an alert in response to the concentration level of the NO reaching a predetermined threshold.

16. The biosensor of claim 15 , wherein the processing circuit is further configured to:

determine a concentration level of glucose in blood flow of the user using the at least one of the plurality of spectral responses obtained at a wavelength with a high absorption coefficient for NO; and

generate an alert in response to the concentration level of the glucose reaching a predetermined threshold.

17. The biosensor of claim 15 , wherein the processing circuit is further configured to:

monitor an insulin response after caloric intake using the at least one of the plurality of spectral responses obtained at a wavelength with a high absorption coefficient for NO.

18. The biosensor of claim 15 , wherein the processing circuit is further configured to:

determine a phase 1 or phase 2 stage of digestion after caloric intake using the at least one of the plurality of spectral responses obtained at a wavelength with a high absorption coefficient for NO.

19. A biosensor implemented in an ear piece, comprising:

an activity monitoring circuit in the ear piece configured to detect an activity level;

a photoplethysmograpy (PPG) circuit in the ear piece configured to detect a plurality of spectral responses at a plurality of wavelengths from light reflected from skin of a user;

a processing circuit configured to:

determine the activity level of the user;

determine a heart rate and an oxygen saturation level using the plurality of spectral responses;

determine the heart rate or the oxygen saturation level reaches a predetermined threshold for the activity level of the user; and

generate an alert and transmit the alert wirelessly to a remote device.

20. The biosensor of claim 19 , comprising:

generating a profile of the user including the heart rate and the oxygen saturation level and an associated activity level of the user.

21. The biosensor of claim 19 , wherein the processing circuit is configured to:

determine a period of sleep using the activity level of the user;

determine the oxygen saturation level is less than a predetermined threshold for a period of sleep; and

generate an alert of sleep apnea and transmit the alert wirelessly to the remote device.

22. The biosensor of claim 19 , wherein the processing circuit is configured to:

determine the activity level of the user meets a predetermined threshold of motion;

determine the oxygen saturation level is less than a predetermined threshold for the activity level of the user; and

generate the alert and transmit the alert wirelessly to the remote device.

23. The biosensor of claim 19 , wherein the processing circuit is configured to:

determine a concentration level of an additional substance in blood flow using the plurality of spectral responses; and

determine an associated activity level of the user.

24. The biosensor of claim 23 , wherein the additional substance in blood flow includes: a medication; NO; glucose; a hemoglobin compound; or a protein or other compound associated with cancer, bilirubin amount and potassium.

25. The biosensor of claim 24 , wherein the processing circuit is configured to:

determine the concentration level of the additional substance in blood flow meets a predetermined threshold associated with an activity level of the user; and

generate another alert of the concentration level of the additional substance and transmit the alert wirelessly to a remote device.

Assignments (5)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 26, 2021
From: SANMINA CORPORATION
To: TRILINEAR BIOVENTURES, LLC
Reel/Frame 056364/0506 →
SECURITY INTEREST Recorded May 11, 2021
From: TRILINEAR BIOVENTURES, LLC
To: SANMINA CORPORATION
Reel/Frame 056205/0739 →
RELEASE OF SECURITY INTEREST Recorded Jun 5, 2019
From: U.S. BANK NATIONAL ASSOCIATION, SOLELY AS NOTES COLLATERAL AGENT
To: SANMINA CORPORATION; HADCO CORPORATION; HADCO SANTA CLARA; SCI TECHNOLOGY; SENSORWISE, INC.
Reel/Frame 049378/0927 →
SECURITY INTEREST Recorded Jan 31, 2019
From: SANMINA CORPORATION
To: U.S. BANK NATIONAL ASSOCIATION, NOT IN ITS INDIVIDUAL CAPACITY BUT SOLELY AS NOTES COLLATERAL AGENT
Reel/Frame 048202/0830 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 8, 2018
From: NEWBERRY, ROBERT STEVEN; RODENCAL, MATTHEW
To: SANMINA CORPORATION
Reel/Frame 047455/0115 →
Continuity (12)
Continuation 15485816 · Apr 12, 2017
Continuation 15276760 · Sep 26, 2016
Continuation In Part 14866500 · Sep 25, 2015
Continuation In Part 15275388 · Sep 24, 2016
Continuation In Part 15275444 · Sep 25, 2016
Provisional Application 62383313 · Sep 2, 2016
Provisional Application 62373283 · Aug 10, 2016
Provisional Application 62312614 · Mar 24, 2016
Provisional Application 62307375 · Mar 11, 2016
Provisional Application 62276934 · Jan 10, 2016
Provisional Application 62194264 · Jul 19, 2015
Related Publication 20190076601A1 · Mar 14, 2019